Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to find out how varenicline works to help people quit smoking.
Varenicline, also known as Chantix™, is an U.S. Food and Drug Administration (FDA) approved
medication that has been shown to help people quit smoking. This study was trying to evaluate
whether varenicline would change the response to smoking and the desire for cigarettes when
compared to an inactive placebo control. This was not a quit smoking treatment study, and
participants were not asked or required to stop smoking while in this study.
Phase:
N/A
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute